Ligand Pharmaceuticals Inc Q2 2021 Earnings Call Transcript - Thomson StreetEvents

Ligand Pharmaceuticals Inc Q2 2021 Earnings Call Transcript

Ligand Pharmaceuticals Inc Q2 2021 Earnings Call Transcript - Thomson StreetEvents
Ligand Pharmaceuticals Inc Q2 2021 Earnings Call Transcript
Published Jul 29, 2021
Published Jul 29, 2021
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of LGND.OQ earnings conference call or presentation 29-Jul-21 8:30pm GMT

  
Report Type:

Transcript

Source:
Company:
Ligand Pharmaceuticals Inc
Ticker
LGND.OQ
Time
8:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Jacob K. Johnson - Stephens Inc., Research Division - Analyst : Maybe just first question for Matt Korenberg on guidance. On sparsentan, it looks like maybe that will be a push for approval in 2022 instead of 2021. I think you have a $6 million milestone from that. Can you just remind us what that milestone is tied to? And is that contemplated in 2021 guidance or should we think about that as a 2022 event?


Question: Jacob K. Johnson - Stephens Inc., Research Division - Analyst : Got it. Super helpful. Thanks for that Matt. And then for Matt Foehr, just on the recent OmniAb deals on the AI capabilities you added via xCella, and it seems like you added to this morning as well. How has that helped business development efforts? Is this something customers were asking for? Does it kind of increase the funnel for OmniAb more broadly? And is this something that's pretty easy to cross-sell?


Question: Jacob K. Johnson - Stephens Inc., Research Division - Analyst : Got it. Thanks, Matt. And then if I could just sneak in one more, just for Matt Korenberg. Just on gross margins, given the dynamics around Captisol sales, I think may be a little bit impacted. They're a little bit lower this quarter, probably due to Veklury sales. As we think about the back half for gross margins, just any help you could give us in terms of how to think about those? REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. JULY 29, 2021 / 8:30PM, LGND.OQ - Q2 2021 Ligand Pharmaceuticals Inc Earnings Call

Table Of Contents

Ligand Pharmaceuticals Inc Q2 2022 Earnings Call Transcript – 2022-08-08 – US$ 54.00 – Edited Transcript of LGND.OQ earnings conference call or presentation 8-Aug-22 8:30pm GMT

Ligand Pharmaceuticals Inc Annual Shareholders Meeting Transcript – 2022-06-10 – US$ 54.00 – Edited Transcript of LGND.OQ shareholder or annual meeting 10-Jun-22 3:30pm GMT

Ligand Pharmaceuticals Inc Q1 2022 Earnings Call Transcript – 2022-05-04 – US$ 54.00 – Edited Transcript of LGND.OQ earnings conference call or presentation 4-May-22 8:30pm GMT

Ligand Pharmaceuticals Inc Q4 2021 Earnings Call Transcript – 2022-02-17 – US$ 54.00 – Edited Transcript of LGND.OQ earnings conference call or presentation 17-Feb-22 9:30pm GMT

Ligand Pharmaceuticals Inc Q3 2021 Earnings Call Transcript – 2021-11-09 – US$ 54.00 – Edited Transcript of LGND.OQ earnings conference call or presentation 9-Nov-21 9:30pm GMT

Ligand Pharmaceuticals Inc Annual Shareholders Meeting Transcript – 2021-06-04 – US$ 54.00 – Edited Transcript of LGND.OQ shareholder or annual meeting 4-Jun-21 3:30pm GMT

Ligand Pharmaceuticals Inc Q1 2021 Earnings Call Transcript – 2021-05-03 – US$ 54.00 – Edited Transcript of LGND.OQ earnings conference call or presentation 3-May-21 8:30pm GMT

Ligand Pharmaceuticals Inc Q4 2020 Earnings Call Transcript – 2021-02-03 – US$ 54.00 – Edited Transcript of LGND.OQ earnings conference call or presentation 3-Feb-21 1:30pm GMT

Ligand Pharmaceuticals Inc Extraordinary Shareholders Meeting Transcript – 2020-12-15 – US$ 54.00 – Edited Transcript of LGND.OQ shareholder or annual meeting 15-Dec-20 4:30pm GMT

Ligand Pharmaceuticals Inc Q3 2020 Earnings Call Transcript – 2020-10-30 – US$ 54.00 – Edited Transcript of LGND.OQ earnings conference call or presentation 30-Oct-20 12:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Ligand Pharmaceuticals Inc Q2 2021 Earnings Call Transcript" Jul 29, 2021. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2021-Ligand-Pharmaceuticals-Inc-Earnings-Call-T14925880>
  
APA:
Thomson StreetEvents. (2021). Ligand Pharmaceuticals Inc Q2 2021 Earnings Call Transcript Jul 29, 2021. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2021-Ligand-Pharmaceuticals-Inc-Earnings-Call-T14925880>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.